Skip to main content
Log in

CYP1A1 polymorphism interactions with smoking status in oral cancer risk: evidence from epidemiological studies

  • Research Article
  • Published:
Tumor Biology

Abstract

The cytochrome CYP1A1 gene has been implicated in the etiology of oral cancer. However, the results have been inconsistent. In this study, a meta-analysis was performed to clarify the associations of polymorphisms in CYP1A1 gene with oral cancer risk. Published literatures from PubMed, MEDLINE, EMBASE, and China National Knowledge infrastructure (CNKI) databases were retrieved. A total of 12 studies were included in this meta-analysis. We found that significant positive associations between CYP1A1*2A polymorphism and oral cancer risk in recessive model (CC vs. TC + TT, OR = 1.93), dominant model (CC + TC vs. TT, OR = 1.33), and additive model (CC vs. TT, OR = 1.97). In subgroup analysis based on the ethnicity of study population, significant associations were found in all three genetic models for Asians (recessive OR = 2.29, 95 % CI = 1.42–3.71; dominant OR = 1.54, 95 % CI = 1.03–2.31; additive OR = 2.39, 95 % CI = 1.47–3.88) but not non-Asians. For the smoking stratification, the result indicated a significant association between CYP1A1*2A polymorphism and oral cancer among the smoking subjects (OR = 1.83, 95 % CI = 1.47–2.26). This meta-analysis indicated a marked association of CYP1A1*2A polymorphisms with oral cancer risk, particularly among Asians, whereas there were significant interactions between the polymorphisms and cigarette smoking on oral cancer risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Zygogianni AG, Kyrgias G, Karakitsos P, Psyrr A, Kouvars J, Kelekis N, et al. Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol. 2011;3:2.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Reichart PA, Nguyen XH. Betel qud chewing, oral cancer and other oral mucosal diseases in Vietnam: a review. J Oral Pathol Med. 2008;37:511–4.

    Article  CAS  PubMed  Google Scholar 

  3. Nerurkar PV, Okinaka L, Aoki C, Seifried A, Lum-Jones A, et al. CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol Biomarkers Prev. 2000;9:1119–22.

    CAS  PubMed  Google Scholar 

  4. Guengerich FP, Shimada T. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res. 1998;400:201–13.

    Article  CAS  PubMed  Google Scholar 

  5. Masson LF, Sharp L, Cotton SC, Little J. Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol. 2005;161:901–15.

    Article  CAS  PubMed  Google Scholar 

  6. Petersen DD, McKinney CE, Ikeya K, Smith HH, Bale AE, et al. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am J Genet. 1991;48:720–5.

    CAS  Google Scholar 

  7. Tanimoto K, Hayashi S, Yoshiga K, Ichikawa T. Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol. 1999;35:191–6.

    Article  CAS  PubMed  Google Scholar 

  8. Balaji L, Singh KB, Bhaskar LV. CYP1A1 genotypes and haplotypes and risk of oral cancer: a case-control study in South Indians. Genet Mol Biol. 2012;35(2):407–12.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Moher D, Liberati A, Tetzlaff J, Altman DG. the PRISMA group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–12.

    Article  PubMed  Google Scholar 

  10. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.

    Article  CAS  PubMed  Google Scholar 

  11. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.

    Article  PubMed  Google Scholar 

  12. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem. 2003;49:1–6.

    Article  CAS  PubMed  Google Scholar 

  13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  14. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    CAS  PubMed  Google Scholar 

  15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

    Article  PubMed  Google Scholar 

  16. Egger M, Davey Smith G, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629–34.

  17. Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR, et al. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol. 2001;37:593–8.

    Article  CAS  PubMed  Google Scholar 

  18. Kao SY, Wu CH, Lin SC, Yap SK, Chang CS, et al. Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use. J Oral Pathol Med. 2002;31:505–11.

    Article  CAS  PubMed  Google Scholar 

  19. Gronau S, Koenig-Greger D, Jerg M, Riechelmann H. GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis. 2003;9:62–7.

    Article  CAS  PubMed  Google Scholar 

  20. Gattas GJ, de Carvalho MB, Siraque MS, Curioni OA, Kohler P, et al. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck. 2006;28:819–26.

    Article  PubMed  Google Scholar 

  21. Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis. 2007;28:1455–62.

    Article  CAS  PubMed  Google Scholar 

  22. Cha IH, Park JY, Chung WY, Choi MA, Kim HJ, et al. Polymorphisms of CYP1A1 and GSTM1 genes and susceptibility to oral cancer. Yonsei Med J. 2007;48:233–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Losi-Guembarovski R, Colus IM, De Menezes RP, Poliseli F, Chaves VN, et al. Lack of association among polymorphic xenobiotic-metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population. Anticancer Res. 2008;28:1023–8.

    CAS  PubMed  Google Scholar 

  24. Cordero K, Espinoza I, Caceres D, Roco A, Miranda C, et al. Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals. Oral Lett. 2010;1:549–33.

    CAS  Google Scholar 

  25. Chatterjee S, Dhar S, Sengupta B, Ghosh A, De M, et al. Polymorphisms of CYP1A1, GSTM1 and GSTT1 loci as the genetic predispositions of oral cancers and other oral pathologies: tobacco and alcohol as risk modifiers. Indian J Clin Biochem. 2010;25:260–72.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Deepika S, Alka Dinesh K, Seema H, Subbiah V, Yerrmalla V. Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer. Biomed Rap Med Fac Univ Palacky Olomouc Czech Repub. 2012;156(3):253–9.

    Article  Google Scholar 

  27. Guo L, Zhang C, Shi S, Guo X. Correlation between smoking and the polymorphisms of cytochrome P450 1A1-Msp I and glutathione S-trans-ferase T1 genes and oral cancer. West China J Stomatology. 2012;2:30.

    Google Scholar 

  28. Singh RD, Haridas N, Shah FD, Patel JB, Shukla SN, et al. Gene polymorphisms, tobacco exposure and oral cancer susceptibility: a study from Gujarat. West India Oral Dis. 2014;20:84–93.

    Article  CAS  Google Scholar 

  29. Zheng Y, Wang JJ, Sun L, Li HL. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis. Mol Biol Rep. 2011; doi: 10.1007/s11033-011-1126-2

  30. Chen Z, Li Z, Niu X, Ye X, Yu Y, et al. The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies. Mutagenesis. 2011;26:437–46.

    Article  CAS  PubMed  Google Scholar 

  31. Sergentanis TN, Economopoulos KP. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;122:459–69.

    Article  CAS  PubMed  Google Scholar 

  32. Shaik AP, Jamil K, Das P. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis. Urol J. 2009;6:78–86.

    PubMed  Google Scholar 

  33. Srivastava K, Srivastava A, Sharma KL, Mittal B. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res. 2011;728:67–79.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  34. Hiyama T, Yoshihara M, Tanaka S, Chayama K. Genetic polymorphisms and head and neck cancer risk (Review). Int J Oncol. 2008;32:945–73.

    CAS  PubMed  Google Scholar 

  35. Devasena A, Amelie C, Valerie G, Silvia F, Rolando H, et al. Genetic variants in nicotine addiction and alcohol metabolism genes, oral cancer risk and the propensity to smoke and drink alcohol: a replication study in India. PLOS ONE. 2014;9(2):e88240.

    Article  Google Scholar 

  36. Zhuo X, Zhao H, Chang A, Zhou Y, et al. Quantitative Assessment of CYP1A1*2A variation with oral carcinoma susceptibility: evidence from 1,438 cases and 2,086 controls. Cancer Investig. 2012;30:552–9.

    Article  CAS  Google Scholar 

  37. Wacholder S, Silverman DT, Mclaughlin JK, Mandel JS. Selection of controls in case-control studies II. Types of controls. Am J Epidemiol. 1992;135:1029–41.

    CAS  PubMed  Google Scholar 

Download references

Conflicts of interests

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shuai Zhen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, KT., Ge, C., Xu, XF. et al. CYP1A1 polymorphism interactions with smoking status in oral cancer risk: evidence from epidemiological studies. Tumor Biol. 35, 11183–11191 (2014). https://doi.org/10.1007/s13277-014-2422-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2422-y

Keywords

Navigation